Gilead Sciences, Inc. (NASDAQ:GILD) will release earnings results for the second quarter, after the closing bell on Thursday, ...

Gilead has returned the rights to a cancer candidate it licensed from Arcus Biosciences in a $725 million, multiprogram deal, ...

President Bill Clinton plans significant changes for this year’s Clinton Global Initiative annual meeting to address global ...

Vizient released its Summer 2025 Spend Management Outlook forecasting a 3.35% increase in pharmaceutical prices in 2026 with healthcare providers seeing increased usage in GLP-1 therapies, specialty ...

Stocks were falling Thursday after President Donald Trump’s sweeping tariffs went into effect and initial jobless claims came in higher than expected.These stocks were moving:Eli Lilly slumped 14% ...

National Health Center Week, being observed Aug. 3 through 9, is an annual event that recognizes the contributions ...